Rising prevalence of HIV-1 non-B subtypes in Belgium: 1983-2001

被引:42
作者
Snoeck, J
Van Laethem, K
Hermans, P
Van Wijngaerden, E
Derdelinckx, I
Schrooten, Y
van de Vijver, DAMC
De Wit, S
Clumeck, N
Vandamme, AM
机构
[1] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium
[2] Univ Hosp Leuven, AIDS Reference Lab, Louvain, Belgium
[3] CHU St Pierre, Div Infect Dis, Brussels, Belgium
[4] Katholieke Univ Leuven, Univ Hosp, Louvain, Belgium
[5] Univ Utrecht, Med Ctr, Dept Virol, Utrecht, Netherlands
关键词
epidemiology; non-B subtypes;
D O I
10.1097/00126334-200403010-00009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This study documented the HIV-1 subtype distribution in 2 Belgian hospitals and determined predictive demographics for non-B subtypes. Overall, subtype B was the most prevalent subtype in this population, followed by subtypes A and C. Several recombinants were detected, circulating recombinants as well as new ones. We found a rise in non-B subtypes from 0% in 1983 to 57% in 2001. The Cochran-Armitage trend test (P < 0.001) as well as the correlation analysis (R = 0.71 P = 0.0006) was highly significant. Recombinants were also increasing in this patient population from 0% in 1983 to 10% in 2001, with good support from the statistical analyses (trend test P < 0.001; correlation analysis R = 0.67, P = 0.0016). Heterosexual route of infection, black African race, African origin of the virus, and year of diagnosis were predictors for infection with non-B subtypes in multivariate analysis. This analysis indicates that the prevalence of non-B subtypes and recombinants in this patient population is high and increasing. Gathering demographic and sequence information from newly diagnosed patients could be useful to further follow the spread of non-B subtypes in Belgium and Europe, but subtyping based on sequence information still remains the most reliable method.
引用
收藏
页码:279 / 285
页数:7
相关论文
共 32 条
[31]   Presence of human immunodeficiency virus (HIV) type 1, group M, non-B subtypes, Bronx, New York: A sentinel site for monitoring HIV genetic diversity in the United States [J].
Weidle, PJ ;
Ganea, CE ;
Irwin, KL ;
Pieniazek, D ;
McGowan, JP ;
Olivo, N ;
Ramos, A ;
Schable, C ;
Lal, RB ;
Holmberg, SD ;
Ernst, JA .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (02) :470-475
[32]   Use of drug resistance sequence data for the systematic detection of non-B human immunodeficiency virus type 1 (HIV-1) subtypes: How to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scale [J].
Yahi, N ;
Fantini, J ;
Tourres, C ;
Tivoli, N ;
Koch, N ;
Tamalet, C .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (09) :1311-1317